Schoelmerich, Juergen (1999) Clinical effects of different budesonide preparations in Crohn's disease. MEDIZINISCHE KLINIK, 94. pp. 29-38. ISSN 0723-5003,
Full text not available from this repository.Abstract
Budesonide in the pH-dependent and time-dependent release preparation is at a dose of 9 mg/day useful for treatment of mild to moderate active Crohn's disease. Although the remission rates are somewhat lower as compared to systemic steroids, the number of side effects is significantly decreased. Differences between both preparations based on theoretical and pharmacological considerations have not yet been proven in clinical practice. With regard to maintenance of steroid-induced remission the data available do not justify continuous treatment. This is also true for postoperative remission maintenance. It is not clear at the moment if higher doses could possible by effective for this indication. It has to be expected, however, that side effects than will increase as well.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | MODIFIED-RELEASE BUDESONIDE; ORAL BUDESONIDE; DRUG-TREATMENT; PREDNISOLONE; ILEOCOLITIS; MAINTENANCE; ILEAL; AZATHIOPRINE; THERAPY; budesonide; time-dependent release; pH-dependent release; active Crohn's disease; Crohn's disease in remission |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin I |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 21 Nov 2022 08:55 |
| Last Modified: | 21 Nov 2022 09:31 |
| URI: | https://pred.uni-regensburg.de/id/eprint/48520 |
Actions (login required)
 |
View Item |
